Physiologically significant thromboembolic disease following total hip arthroplasty. A prospective study.
A prospective study was performed of 115 patients without previous history of thromboembolic disease undergoing 117 total hip arthroplasties. No prophylactic anticoagulants were used; two patients developed physiologically significant thromboembolic disease. No deaths were encountered. This incidence of 1.7% is significantly (p = 0.05) lower than that of previous reports and compares favorable with the incidence of complications encountered with prophylactic anticoagulation therapy itself.
D000368:Aged; D005081:Exercise Therapy; D005260:Female; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000209:etiology / Q000517:prevention & control; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control